EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Best medical treatment in patients with PAD

Yvonne Rosenberg, Christian-Alexander Behrendt

Vasa · 2023

DOI: 10.1024/0301-1526/a001076 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Vasa, 2023. Verfasst von Yvonne Rosenberg und 1 weiteren Autor:innen. Beteiligte Einrichtung: Research Group GermanVasc, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany. Hauptthemen laut MEDLINE: Quality of Life, Peripheral Arterial Disease. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 45 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Guidelines recommend comprehensive lifestyle change in patients with peripheral arterial disease (PAD) to prevent cardiovascular events and death. When compared with other populations, patients with PAD are less likely to receive best medical therapies (BMT). The aim of this pilot study was to integrate all aspects of BMT in an intervention program and to determine the feasibility of such an approach by highlighting strengths and obstacles of a multi-aspect intervention. Patients and methods: Patients consecutively hospitalized due to symptomatic PAD between 01 December 2021 and 28 February 2022 were included and followed for ten weeks. We randomized into a lifestyle intervention (education on BMT, a list of regional contact data for supervised exercise, weekly counselling by phone for ten times) vs. standard of care (one contact to talk about BMT). Vascular Quality of Life Questionnaire – 6 (VascuQoL-6) was used to collect patient reported outcomes.

Results

Of 50 eligible patients 40 agreed to participate (32.5% female, 72.5 years in mean). During follow-up nine patients dropped out (4 in intervention group vs. 5). As for risk factor modification one patient was able to reach a normal weight body-mass-index (BMI) and nine reduced weight. Two patients stopped smoking, three reduced their consumption. The reported adherence to medication was a hundred percent. No patient attended supervised exercise therapy but eight trained at a home-based setting according to guidelines. The mean score of VascuQoL-6 at follow-up was higher in the intervention group compared to the control group (17.4 vs. 13.8 points) at last contact with both groups increasing from baseline.

Conclusions

This pilot study followed 40 patients for up to 10 weeks after inpatient treatment while we randomized a multi-aspect lifestyle intervention versus standard of care. Thereby, the current study illustrated the numerous obstacles and provided pragmatic solutions for the planning of studies on BMT in this target population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Quality of LifePeripheral Arterial DiseaseHumansFemaleMalePilot ProjectsExerciseLife Style

Stichwörter der Autor:innen

Peripheral arterial diseasehealth services researchlifestyleoutcomesprevention

Autor:innen und Institutionen

  • Research Group GermanVasc, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.
  • Department of Vascular and Endovascular Surgery, Asklepios Clinic Wandsbek, Hamburg, Germany.
  • Brandenburg Medical School Theodor Fontane, Neuruppin, Germany.

Zitieren

APA

Rosenberg, Y., & Behrendt, C. A. (2023). Best medical treatment in patients with PAD. Vasa. https://doi.org/10.1024/0301-1526/a001076

Vancouver

Rosenberg Y, Behrendt CA. Best medical treatment in patients with PAD. Vasa. 2023. doi:10.1024/0301-1526/a001076

BibTeX
@article{Rosenberg2023,
  author = {Rosenberg, Yvonne and Behrendt, Christian-Alexander},
  title = {Best medical treatment in patients with PAD},
  journal = {Vasa},
  year = {2023},
  doi = {10.1024/0301-1526/a001076}
}
Kostenlos starten →